Ying-chun XU, Jing-jing HUANG, Meng XIAO, Xin-fei CHEN, Ya-ting NING, Xin FAN, Yang YANG, Jia-jia FENG, Li-kai LIN. Current Status of Clinical Infection of Candida Auris in China[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(5): 442-445. DOI: 10.3969/j.issn.1674-9081.2019.05.003
Citation: Ying-chun XU, Jing-jing HUANG, Meng XIAO, Xin-fei CHEN, Ya-ting NING, Xin FAN, Yang YANG, Jia-jia FENG, Li-kai LIN. Current Status of Clinical Infection of Candida Auris in China[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(5): 442-445. DOI: 10.3969/j.issn.1674-9081.2019.05.003

Current Status of Clinical Infection of Candida Auris in China

  • Candida auris is an emerging pathogen in recent years that has developed resistance and caused nosocomial outbreaks in some countries especially in the United States. The term "super fungi" derived from "superbug", and it is rarely mentioned in the field of fungi. However, recently the articles with the definition that "Candida auris is a super fungi" are widely circulated on the internet. The situation of Candida auris in China differs from that in the United States according to existing reports and epidemiological surveillance data. The infection caused by it is still sporadic, and isolations of Candida auris are active to antifungal agents. Meanwhile, its pathogenicity is not stronger than the common non-albican Candida species. Therefore, the public should avoid excessive interpretation of the articles with unnecessary panic.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return